ARCHIVES

Controversy Continues, Scientists, Advocates, Clinicians Say

This article is from The Cancer Letter archive.

Vol. 23 No. 04 | January 31, 1997

Download PDF Visit The Full Archive

Related Articles

ASCO Recommends Beginning Palliative Care Alongside Standard Therapy in Metastatic NSCLC

February 24, 2012

Herberman Leaving NCI To Head New Pittsburgh Institute

July 12, 1985

Chemical Industry Sues NTP Over Listing PDC As Carcinogen; Environmental Groups Join Defense

June 23, 1989

In Brief: William Blot, Michael Grever, Others To Leave NCI; RAC Approves Naked DNA Vaccine Trial

June 17, 1994

FDA developing guidelines for oncology endpoints.

May 7, 2004

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012